Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment

Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment

Fatma Amer,1 Monkez M Yousif,2 Noha M Hammad,1 Damir Garcia-Cehic,3,4 Josep Gregori,3–5 Ariadna Rando-Segura,6 Leonardo Nieto-Aponte,6 Juan Ignacio Esteban,3,4 Francisco Rodriguez-Frias,4,6 Josep Quer3,4 1Department of Medical Microbiology and Immunology, Faculty of Medicine, Medical Colle...

Full description

Bibliographic Details
Main Authors: Amer F, Yousif MM, Hammad NM, Garcia-Cehic D, Gregori J, Rando-Segura A, Nieto-Aponte L, Esteban JI, Rodriguez-Frias F, Quer J
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Infection and Drug Resistance
Subjects:
resistance-associated substitutions (RAS)
subtype 4a
treatment failure
Egypt
direct acting antivirals (DAA)
Online Access:https://www.dovepress.com/deep-sequencing-study-of-hcv-g4a-resistance-associated-substitutions-i-peer-reviewed-article-IDR

Internet

https://www.dovepress.com/deep-sequencing-study-of-hcv-g4a-resistance-associated-substitutions-i-peer-reviewed-article-IDR

Similar Items